OMB APPROVAL | ||||
OMB Number: | 3235-0570 | |||
Expires: | January 31, 2014 | |||
Estimated average burden | ||||
hours per response: | 20.6 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF
REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-21553
ING Global Equity Dividend and Premium Opportunity Fund
(Exact name of registrant as specified in charter)
7337 E. Doubletree Ranch Rd., Scottsdale, AZ | 85258 | |
(Address of principal executive offices) | (Zip code) |
The Corporation Trust Company, 1209 Orange
Street, Wilmington, DE 19801
(Name and address of agent for service)
Registrants telephone number, including area code: 1-800-992-0180
Date of fiscal year end: February 29
Date of reporting period: August 31, 2012
Item 1. | Reports to Stockholders. |
The following is a copy of the report transmitted to stockholders pursuant to Rule 30e-1 under the Act (17 CFR 270.30e-1):
This report is submitted for general information to
shareholders of the ING Funds. It is not authorized for distribution to prospective shareholders unless accompanied or preceded by a prospectus which
includes details regarding the funds investment objectives, risks, charges, expenses and other information. This information should be read
carefully. |
MUTUAL FUNDS |
Presidents
Letter |
1 | |||||
Market
Perspective |
2 | |||||
Portfolio
Managers Report |
4 | |||||
Statement of
Assets and Liabilities |
6 | |||||
Statement of
Operations |
7 | |||||
Statements of
Changes in Net Assets |
8 | |||||
Financial
Highlights |
9 | |||||
Notes to
Financial Statements |
10 | |||||
Summary
Portfolio of Investments |
19 | |||||
Shareholder
Meeting Information |
24 | |||||
Additional
Information |
25 |
Go Paperless with E-Delivery! |
|||||||||||
Sign up
now for on-line prospectuses, fund reports, and proxy statements. In less than five minutes, you can help reduce paper mail and lower fund
costs. |
|||||||||||
Just go
to www.inginvestment.com, click on the E-Delivery icon from the home page, follow the directions and complete the quick 5 Steps to
Enroll. |
|||||||||||
You
will be notified by e-mail when these communications become available on the internet. Documents that are not available on the internet will continue
to be sent by mail. |
Dear Shareholder,
(1) |
Total investment return at net asset value has been calculated assuming a purchase at net asset value at the beginning of each period and a sale at net asset value at the end of each period and assumes reinvestment of dividends, capital gain distributions, and return of capital distributions/allocations, if any, in accordance with the provisions of the Funds dividend reinvestment plan. |
(2) |
Total investment return at market value measures the change in the market value of your investment assuming reinvestment of dividends, capital gain distributions, and return of capital distributions/allocations, if any, in accordance with the provisions of the Funds dividend reinvestment plan. |
Index | Description | |||||
---|---|---|---|---|---|---|
MSCI World
IndexSM |
An
unmanaged index that measures the performance of over 1,400 securities listed on exchanges in the U.S., Europe, Canada, Australia, New Zealand and the
Far East. |
|||||
Barclays Capital
U.S. Aggregate Bond Index |
An
unmanaged index of publicly issued investment grade U.S. Government, mortgage-backed, asset-backed and corporate debt securities. |
|||||
Barclays Capital
U.S. Corporate Investment Grade Bond Index |
An
unmanaged index consisting of publicly issued, fixed rate, nonconvertible, investment grade debt securities. |
|||||
Barclays Capital
U.S. Treasury Index |
An
unmanaged index that includes public obligations of the U.S. Treasury. Treasury bills, certain special issues, such as state and local government
series bonds (SLGs), as well as U.S. Treasury TIPS and STRIPS, are excluded. |
|||||
Barclays Capital
High Yield Bond 2% Issuer Constrained Composite Index |
An
unmanaged index that includes all fixed-income securities having a maximum quality rating of Ba1, a minimum amount outstanding of $150 million, and at
least one year to maturity. |
|||||
S&P 500®
Index |
An
unmanaged index that measures the performance of securities of approximately 500 large-capitalization companies whose securities are traded on major
U.S. stock markets. |
|||||
MSCI Japan®
Index |
A
free float-adjusted market capitalization index that is designed to measure developed market equity performance in Japan. |
|||||
MSCI Europe ex
UK® Index |
A
free float-adjusted market capitalization index that is designed to measure developed market equity performance in Europe, excluding the
UK. |
|||||
MSCI UK®
Index |
A
free float-adjusted market capitalization index that is designed to measure developed market equity performance in the UK. |
|||||
Chicago Board
Options Exchange BuyWrite Monthly Index (CBOE BuyWrite Monthly Index) |
A
passive total return index based on selling the near-term, at-the-money S&P 500® Index call option against the S&P 500® stock index
portfolio each month, on the day the current contract expires. |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
PORTFOLIO MANAGERS REPORT |
Geographic Diversification as of August 31, 2012 (as a percentage of net assets) |
||||||||
United
States |
39.9 | % | ||||||
United
Kingdom |
14.7 | % | ||||||
France |
8.1 | % | ||||||
Japan |
8.0 | % | ||||||
Germany |
5.9 | % | ||||||
Switzerland |
3.9 | % | ||||||
Netherlands |
3.8 | % | ||||||
Canada |
3.2 | % | ||||||
Australia |
2.8 | % | ||||||
Sweden |
1.7 | % | ||||||
Countries between 0.5%1.7%ˆ |
6.8 | % | ||||||
Assets
in Excess of Other Liabilities |
1.2 | % | ||||||
Net
Assets |
100.0 | % | ||||||
ˆ Includes 7 countries, which each represents 0.5%1.7% of net assets. |
||||||||
Portfolio holdings are subject to change daily. |
Top Ten Holdings as of August 31, 2012 (as a percentage of net assets) |
||||||||
Metlife, Inc. |
1.8 | % | ||||||
Deutsche Telekom AG |
1.7 | % | ||||||
JPMorgan Chase & Co. |
1.7 | % | ||||||
Telefonaktiebolaget LM Ericsson |
1.7 | % | ||||||
Novartis AG |
1.7 | % | ||||||
ExxonMobil Corp. |
1.7 | % | ||||||
General Electric Co. |
1.7 | % | ||||||
Microsoft Corp. |
1.7 | % | ||||||
Abbott
Laboratories |
1.6 | % | ||||||
HSBC
Holdings PLC |
1.6 | % | ||||||
Portfolio holdings are subject to change daily. |
PORTFOLIO MANAGERS REPORT | ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
ASSETS: |
||||||
Investments in
securities at fair value* |
$ | 916,714,616 | ||||
Cash |
20,639,879 | |||||
Cash collateral
for futures |
3,824 | |||||
Foreign
currencies at value** |
644,100 | |||||
Foreign cash
collateral for futures*** |
19,283 | |||||
Receivables: |
||||||
Dividends |
3,634,069 | |||||
Foreign tax
reclaims |
966,645 | |||||
Prepaid
expenses |
3,561 | |||||
Total
assets |
942,625,977 | |||||
LIABILITIES: |
||||||
Payable for
investment management fees |
713,846 | |||||
Payable for
administrative fees |
78,884 | |||||
Payable for
trustee fees |
3,893 | |||||
Other accrued
expenses and liabilities |
314,853 | |||||
Written
options, at fair valueˆ |
13,634,718 | |||||
Total
liabilities |
14,746,194 | |||||
NET
ASSETS |
$ | 927,879,783 | ||||
NET ASSETS
WERE COMPRISED OF: |
||||||
Paid-in
capital |
$ | 1,360,987,589 | ||||
Undistributed
net investment income |
1,284,854 | |||||
Accumulated net
realized loss |
(460,498,234 | ) | ||||
Net unrealized
appreciation |
26,105,574 | |||||
NET
ASSETS |
$ | 927,879,783 | ||||
_______________ | ||||||
* Cost of
investments in securities |
$ | 889,949,339 | ||||
** Cost of
foreign currencies |
$ | 642,912 | ||||
*** Cost of
foreign cash collateral for futures |
$ | 19,283 | ||||
ˆ Premiums
received on written options |
$ | 13,024,623 | ||||
Net
assets |
$ | 927,879,783 | ||||
Shares
authorized |
unlimited | |||||
Par
value |
$ | 0.01 | ||||
Shares
outstanding |
97,548,925 | |||||
Net asset value
and redemption price per share |
$ | 9.51 |
INVESTMENT
INCOME: |
||||||
Dividends, net
of foreign taxes withheld* |
$ | 23,373,023 | ||||
Total
investment income |
23,373,023 | |||||
EXPENSES: |
||||||
Investment
management fees |
4,907,240 | |||||
Transfer agent
fees |
15,456 | |||||
Administrative
service fees |
467,331 | |||||
Shareholder
reporting expense |
88,596 | |||||
Professional
fees |
38,666 | |||||
Custody and
accounting expense |
103,734 | |||||
Trustee
fees |
12,042 | |||||
Miscellaneous
expense |
94,034 | |||||
Total
expenses |
5,727,099 | |||||
Net waived
and reimbursed fees |
(276,293 | ) | ||||
Net
expenses |
5,450,806 | |||||
Net investment
income |
17,922,217 | |||||
REALIZED AND
UNREALIZED GAIN (LOSS): |
||||||
Net realized
gain (loss) on: |
||||||
Investments |
15,838,854 | |||||
Foreign
currency related transactions |
(111,560 | ) | ||||
Written
options |
(7,259,280 | ) | ||||
Net realized
gain |
8,468,014 | |||||
Net change in
unrealized appreciation (depreciation) on: |
||||||
Investments |
(25,605,482 | ) | ||||
Foreign
currency related transactions |
(33,869 | ) | ||||
Futures |
4,746 | |||||
Written
options |
4,871,052 | |||||
Net change in
unrealized appreciation (depreciation) |
(20,763,553 | ) | ||||
Net realized
and unrealized loss |
(12,295,539 | ) | ||||
Increase in
net assets resulting from operations |
$ | 5,626,678 | ||||
_______________ | ||||||
* Foreign
taxes withheld |
$ | 1,757,529 |
Six Months Ended August 31, 2012 |
Year Ended February 29, 2012 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
FROM
OPERATIONS: |
||||||||||
Net investment
income |
$ | 17,922,217 | $ | 34,870,812 | ||||||
Net realized
gain (loss) |
8,468,014 | (10,907,488 | ) | |||||||
Net change in
unrealized (depreciation) |
(20,763,553 | ) | (42,671,156 | ) | ||||||
Increase
(decrease) in net assets resulting from operations |
5,626,678 | (18,707,832 | ) | |||||||
FROM
DISTRIBUTIONS TO SHAREHOLDERS: |
||||||||||
Net investment
income |
(17,678,406 | ) | (25,259,004 | ) | ||||||
Return of
capital |
(36,753,893 | ) | (90,325,438 | ) | ||||||
Total
distributions |
(54,432,299 | ) | (115,584,442 | ) | ||||||
FROM CAPITAL
SHARE TRANSACTIONS: |
||||||||||
Reinvestment of
distributions |
| 2,278,652 | ||||||||
Net increase in
net assets resulting from capital share transactions |
| 2,278,652 | ||||||||
Net decrease in
net assets |
(48,805,621 | ) | (132,013,622 | ) | ||||||
NET
ASSETS: |
||||||||||
Beginning of
year or period |
976,685,404 | 1,108,699,026 | ||||||||
End of year or
period |
$ | 927,879,783 | $ | 976,685,404 | ||||||
Undistributed
net investment income at end of year or period |
$ | 1,284,854 | $ | 1,041,043 |
Per Share Operating Performance |
Ratios and Supplemental Data |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Income (loss) from investment operations |
Less distributions |
Ratios to average net assets |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net asset value, beginning of year or period |
Net investment income |
|
Net realized and unrealized gain (loss) |
Total from investment operations |
From net investment income |
|
From net realized gains |
|
From return of capital |
Total distributions |
Adjustment to paid-in capital for offering cost |
Net asset value, end of year or period |
Market Value, end of year or period |
Total Investment Return at net asset value (1) |
Total Investment Return at market value(2) |
Net assets, end of year or period 000s |
Gross expenses prior to expense waiver (3) |
|
Net expenses after expense waiver (3)(4) |
|
Net investment income (loss) (3)(4) |
|
Portfolio Turnover |
||||||||||||||||||||||||||||||||||||||||
Year or period ended |
($) |
($) |
|
($) |
($) |
($) |
|
($) |
|
($) |
($) |
($) |
(%) |
(%) |
(%) |
(%) |
($000s) |
(%) |
|
(%) |
|
(%) |
|
(%) |
|||||||||||||||||||||||||||||||||||||||
08-31-12 |
10.01 | 0.18 | (0.12 | ) | 0.06 | 0.18 | | 0.38 | 0.56 | | 9.51 | 9.26 | 0.95 | 2.93 | 927,880 | 1.22 | 1.17 | 3.84 | 36 | ||||||||||||||||||||||||||||||||||||||||||||
02-29-12 |
11.39 | 0.36 | | (0.55 | ) | (0.19 | ) | 0.26 | | 0.93 | 1.19 | | 10.01 | 9.56 | (1.13 | ) | (3.28 | ) | 976,685 | 1.24 | 1.14 | 3.45 | 90 | ||||||||||||||||||||||||||||||||||||||||
02-28-11 |
11.58 | 0.35 | 0.76 | 1.11 | 0.82 | | 0.48 | 1.30 | | 11.39 | 11.12 | 10.44 | 0.29 | 1,108,699 | 1.22 | 1.07 | 3.16 | 58 | |||||||||||||||||||||||||||||||||||||||||||||
02-28-10 |
9.81 | 0.38 | 3.17 | 3.55 | 0.30 | | 1.48 | 1.78 | | 11.58 | 12.45 | 38.12 | 78.96 | 1,117,910 | 1.23 | 1.03 | 3.34 | 72 | |||||||||||||||||||||||||||||||||||||||||||||
02-28-09 |
17.39 | 0.68 | | (6.39 | ) | (5.71 | ) | 0.95 | | 0.92 | 1.87 | | 9.81 | 8.14 | (34.02 | ) | (45.09 | ) | 947,889 | 1.22 | 1.02 | 4.76 | 84 | ||||||||||||||||||||||||||||||||||||||||
02-29-08 |
19.98 | 0.66 | | (1.18 | ) | (0.52 | ) | 0.61 | 1.35 | 0.11 | 2.07 | | 17.39 | 17.34 | (2.74 | ) | (5.71 | ) | 1,691,458 | 1.23 | 1.03 | 3.40 | 79 | ||||||||||||||||||||||||||||||||||||||||
02-28-07 |
19.08 | 0.67 | | 2.09 | 2.76 | 0.57 | 1.24 | 0.06 | 1.87 | 0.01 | 19.98 | 20.55 | 15.32 | 19.35 | 1,933,397 | 1.21 | 1.01 | 3.43 | 119 | ||||||||||||||||||||||||||||||||||||||||||||
03-31-05(5)02-28-06 |
19.06 | (6) | 0.63 | 0.79 | 1.42 | 0.66 | 0.43 | 0.31 | 1.40 | | 19.08 | 18.96 | 7.84 | 2.13 | 1,825,844 | 1.23 | 1.03 | 3.75 | 112 | ||||||||||||||||||||||||||||||||||||||||||||
(1) |
Total investment return at net asset value has been calculated assuming a purchase at net asset value at the beginning of each period and a sale at net asset value at the end of each period and assumes reinvestment of dividends, capital gain distributions and return of capital distributions/allocations, if any, in accordance with the provisions of the dividend reinvestment plan. Total investment return at net asset value is not annualized for periods less than one year. | |
(2) |
Total investment return at market value measures the change in the market value of your investment assuming reinvestment of dividends, capital gain distributions and return of capital distributions/allocations, if any, in accordance with the provisions of the Funds dividend reinvestment plan. Total investment return at market value is not annualized for periods less than one year. | |
(3) |
Annualized for periods less than one year. | |
(4) |
The Investment Advisor has contractually agreed to waive a portion of its fee equivalent to 0.20% of the Funds managed assets for the first five years of the Funds existence. Beginning in the sixth year, the fee waiver will decline each year by 0.05% until it is eliminated in the ninth year. | |
(5) |
Commencement of operations. | |
(6) |
Net asset value at beginning of period reflects the deduction of the sales load of $0.90 per share and the offering costs of $0.04 per share paid by the shareholder from the $20.00 offering price. | |
|
Calculated using average number of shares outstanding throughout the period. |
(1) |
Market value of investment securities, other assets and liabilities at the exchange rates prevailing at the end of the day. | |
(2) |
Purchases and sales of investment securities, income and expenses at the rates of exchange prevailing on the respective dates of such transactions. |
USD NOTIONAL |
Cost |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Balance at
02/29/12 |
$ | 163,000,000 | $ | 1,087,600 | ||||||
Options
Purchased |
310,500,000 | 1,852,825 | ||||||||
Options
Expired |
(240,000,000 | ) | (1,569,400 | ) | ||||||
Options
Exercised |
| | ||||||||
Options
Terminated in Closing Sell Transactions |
(84,000,000 | ) | (516,000 | ) | ||||||
Balance at
08/31/12 |
$ | 149,500,000 | $ | 855,025 |
USD NOTIONAL |
Premiums Received |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Balance at
02/29/12 |
$ | 163,000,000 | $ | 1,087,600 | ||||||
Options
Written |
310,500,000 | 1,852,825 | ||||||||
Options
Expired |
(304,000,000 | ) | (1,965,400 | ) | ||||||
Options
Exercised |
| | ||||||||
Options
Terminated in Closing Purchase Transactions |
(20,000,000 | ) | (120,000 | ) | ||||||
Balance at
08/31/12 |
$ | 149,500,000 | $ | 855,025 |
Number of Contracts |
Premiums Received |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Balance at
02/29/12 |
893,200 | $ | 12,608,077 | |||||||
Options
Written |
3,580,100 | 55,391,699 | ||||||||
Options
Expired |
(1,470,100 | ) | (20,085,966 | ) | ||||||
Options
Exercised |
| | ||||||||
Options
Terminated in Closing Purchase Transactions |
(2,180,100 | ) | (35,744,212 | ) | ||||||
Balance at
08/31/12 |
823,100 | $ | 12,169,598 |
Reinvestment of distributions |
Net increase in shares outstanding |
Reinvestment of distributions |
Net increase |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year or period ended |
# |
# |
($) |
($) |
||||||||||||||
8/31/2012 |
| | | | ||||||||||||||
2/29/2012 |
216,490 | 216,490 | 2,278,652 | 2,278,652 |
Tax Year Ended December 31, 2011 |
||||||||
---|---|---|---|---|---|---|---|---|
Ordinary Income |
Return of Capital |
|||||||
$31,004,604 |
$85,241,031 |
Capital Loss Carryforwards |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unrealized Appreciation/ (Depreciation) |
Amount |
Character |
Expiration |
||||||||||||
$(12,929,996) | $ | (106,960,018 | ) | Short-term | 2016 | ||||||||||
(325,327,424 | ) | Short-term | 2017 | ||||||||||||
(11,778,434 | ) | Long-term | None | ||||||||||||
$ | (444,065,876 | ) |
Per Share Amount |
Declaration Date |
Payable Date |
Record Date |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$0.093 | 8/15/2012 | 9/17/2012 | 9/6/2012 | |||||||||||
$0.084 | 9/17/2012 | 10/15/2012 | 10/3/2012 |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
SUMMARY PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) |
Shares |
|
|
|
Value |
|
Percentage of Net Assets |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COMMON STOCK: 98.8% |
|||||||||||||||||||
Australia: 2.8% |
|||||||||||||||||||
1,311,997 |
Amcor Ltd. |
$ | 10,232,567 | 1.1 | |||||||||||||||
955,194 |
Westfield Group |
9,818,496 | 1.1 | ||||||||||||||||
1,377,795 |
Other Securities |
5,933,273 | 0.6 | ||||||||||||||||
25,984,336 | 2.8 | ||||||||||||||||||
Brazil: 0.5% |
|||||||||||||||||||
240,200 |
Other Securities |
4,943,316 | 0.5 | ||||||||||||||||
Canada: 3.2% |
|||||||||||||||||||
130,300 |
Canadian Imperial Bank of Commerce |
10,076,357 | 1.1 | ||||||||||||||||
500,228 |
Shaw Communications, Inc.Class B |
10,230,379 | 1.1 | ||||||||||||||||
209,764 |
TransCanada Corp. |
9,448,158 | 1.0 | ||||||||||||||||
29,754,894 | 3.2 | ||||||||||||||||||
France: 8.1% |
|||||||||||||||||||
273,278 |
Alstom |
9,709,281 | 1.0 | ||||||||||||||||
253,147 |
BNP Paribas |
10,956,228 | 1.2 | ||||||||||||||||
254,309 |
Capgemini S.A. |
9,331,995 | 1.0 | ||||||||||||||||
289,688 |
Cie de Saint-Gobain |
9,921,254 | 1.1 | ||||||||||||||||
389,902 |
Gaz de France |
9,583,811 | 1.0 | ||||||||||||||||
124,218 |
Sanofi-Aventis |
10,161,005 | 1.1 | ||||||||||||||||
220,825 |
Vinci S.A. |
9,586,161 | 1.1 | ||||||||||||||||
173,993 |
Other Securities |
5,344,199 | 0.6 | ||||||||||||||||
74,593,934 | 8.1 | ||||||||||||||||||
Germany: 5.9% |
|||||||||||||||||||
122,135 |
Bayer AG |
9,458,070 | 1.0 | ||||||||||||||||
203,656 |
DaimlerChrysler AG |
9,960,984 | 1.1 | ||||||||||||||||
1,328,988 |
Deutsche Telekom AG |
15,852,148 | 1.7 | ||||||||||||||||
317,536 |
Metro AG |
9,550,761 | 1.0 | ||||||||||||||||
68,109 |
Muenchener Rueckversicherungs AG |
10,064,918 | 1.1 | ||||||||||||||||
54,886,881 | 5.9 | ||||||||||||||||||
Hong Kong: 1.0% |
|||||||||||||||||||
178,004 |
China Mobile Ltd. ADR |
9,557,035 | 1.0 | ||||||||||||||||
Israel: 1.0% |
|||||||||||||||||||
843,566 |
Israel Chemicals Ltd. |
9,164,167 | 1.0 | ||||||||||||||||
Japan: 8.0% |
|||||||||||||||||||
192,700 |
Astellas Pharma, Inc. |
9,435,859 | 1.0 | ||||||||||||||||
272,000 |
Canon, Inc. |
9,066,375 | 1.0 | ||||||||||||||||
154,900 |
East Japan Railway Co. |
10,399,099 | 1.1 | ||||||||||||||||
890,900 |
Itochu Corp. |
9,086,783 | 1.0 | ||||||||||||||||
1,983,400 |
Mitsubishi UFJ Financial Group, Inc. |
9,066,514 | 1.0 | ||||||||||||||||
645,900 |
Mitsui & Co., Ltd. |
9,072,189 | 1.0 | ||||||||||||||||
295,300 |
Sumitomo Mitsui Financial Group, Inc. |
9,197,369 | 1.0 | ||||||||||||||||
959,700 |
Other Securities |
9,000,082 | 0.9 | ||||||||||||||||
74,324,270 | 8.0 | ||||||||||||||||||
Luxembourg: 1.0% |
|||||||||||||||||||
634,932 |
ArcelorMittal |
9,389,622 | 1.0 | ||||||||||||||||
Netherlands: 3.8% |
|||||||||||||||||||
1,911,189 |
Aegon NV |
$ | 9,810,392 | 1.1 | |||||||||||||||
1,154,007 |
Koninklijke KPN NV |
9,896,056 | 1.1 | ||||||||||||||||
429,412 |
Royal Dutch Shell PLC |
15,021,831 | 1.6 | ||||||||||||||||
34,728,279 | 3.8 | ||||||||||||||||||
Portugal: 0.5% |
|||||||||||||||||||
2,046,392 |
Other Securities |
4,992,042 | 0.5 | ||||||||||||||||
Singapore: 1.7% |
|||||||||||||||||||
702,000 |
United Overseas Bank Ltd. |
10,770,218 | 1.2 | ||||||||||||||||
1,721,000 |
Other Securities |
4,683,354 | 0.5 | ||||||||||||||||
15,453,572 | 1.7 | ||||||||||||||||||
Sweden: 1.7% |
|||||||||||||||||||
1,683,030 |
Telefonaktiebolaget LM Ericsson |
15,713,733 | 1.7 | ||||||||||||||||
Switzerland: 3.9% |
|||||||||||||||||||
265,485 |
Novartis AG |
15,655,815 | 1.7 | ||||||||||||||||
55,300 |
Roche Holding AGGenusschein |
10,053,186 | 1.1 | ||||||||||||||||
42,928 |
@ |
Zurich Financial Services AG |
10,303,482 | 1.1 | |||||||||||||||
36,012,483 | 3.9 | ||||||||||||||||||
Taiwan: 1.1% |
|||||||||||||||||||
673,658 |
Taiwan Semiconductor Manufacturing Co., Ltd. ADR |
9,902,773 | 1.1 | ||||||||||||||||
United Kingdom: 14.7% |
|||||||||||||||||||
329,652 |
BHP Billiton PLC |
9,647,720 | 1.0 | ||||||||||||||||
1,424,019 |
BP PLC |
9,988,852 | 1.1 | ||||||||||||||||
2,673,760 |
BT Group PLC |
9,235,935 | 1.0 | ||||||||||||||||
896,836 |
Capita Group PLC |
10,276,771 | 1.1 | ||||||||||||||||
201,600 |
@ |
Ensco PLC |
11,565,792 | 1.3 | |||||||||||||||
1,744,998 |
HSBC Holdings PLC |
15,201,249 | 1.6 | ||||||||||||||||
389,002 |
Imperial Tobacco Group PLC |
15,176,937 | 1.6 | ||||||||||||||||
757,736 |
Land Securities Group PLC |
9,507,247 | 1.0 | ||||||||||||||||
796,021 |
Prudential PLC |
9,943,802 | 1.1 | ||||||||||||||||
177,112 |
Reckitt Benckiser PLC |
10,016,193 | 1.1 | ||||||||||||||||
1,111,063 |
Reed Elsevier PLC |
10,416,656 | 1.1 | ||||||||||||||||
1,972,993 |
Tesco PLC |
10,536,791 | 1.1 | ||||||||||||||||
109,081 |
Other Securities |
5,102,475 | 0.6 | ||||||||||||||||
136,616,420 | 14.7 | ||||||||||||||||||
United States: 39.9% |
|||||||||||||||||||
232,214 |
Abbott Laboratories |
15,219,306 | 1.6 | ||||||||||||||||
255,700 |
Analog Devices, Inc. |
10,161,518 | 1.1 | ||||||||||||||||
295,700 |
Bristol-Myers Squibb Co. |
9,761,057 | 1.1 | ||||||||||||||||
271,900 |
Carnival Corp. |
9,429,492 | 1.0 | ||||||||||||||||
108,800 |
Caterpillar, Inc. |
9,283,904 | 1.0 | ||||||||||||||||
239,900 |
CenturyTel, Inc. |
10,138,174 | 1.1 | ||||||||||||||||
89,100 |
Chevron Corp. |
9,993,456 | 1.1 | ||||||||||||||||
317,200 |
Dow Chemical Co. |
9,297,132 | 1.0 | ||||||||||||||||
216,200 |
Eli Lilly & Co. |
9,709,542 | 1.0 | ||||||||||||||||
177,700 |
ExxonMobil Corp. |
15,513,210 | 1.7 |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
SUMMARY PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) (CONTINUED) |
Shares |
|
|
|
Value |
|
Percentage of Net Assets | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COMMON STOCK: (continued) |
|||||||||||||||||||
United States: (continued) |
|||||||||||||||||||
260,400 |
Freeport-McMoRan Copper & Gold, Inc. |
$ | 9,403,044 | 1.0 | |||||||||||||||
748,400 |
General Electric Co. |
15,499,364 | 1.7 | ||||||||||||||||
135,400 |
Johnson & Johnson |
9,130,022 | 1.0 | ||||||||||||||||
426,600 |
JPMorgan Chase & Co. |
15,843,924 | 1.7 | ||||||||||||||||
234,871 |
Kraft Foods, Inc. |
9,754,193 | 1.1 | ||||||||||||||||
491,300 |
Metlife, Inc. |
16,768,069 | 1.8 | ||||||||||||||||
500,700 |
Microsoft Corp. |
15,431,574 | 1.7 | ||||||||||||||||
230,400 |
Molson Coors Brewing Co. |
10,262,016 | 1.1 | ||||||||||||||||
240,200 |
Northeast Utilities |
9,048,334 | 1.0 | ||||||||||||||||
109,000 |
Occidental Petroleum Corp. |
9,266,090 | 1.0 | ||||||||||||||||
131,500 |
PepsiCo, Inc. |
9,524,545 | 1.0 | ||||||||||||||||
405,658 |
Pfizer, Inc. |
9,679,000 | 1.0 | ||||||||||||||||
1,006,192 |
Pitney Bowes, Inc. |
13,442,725 | 1.4 | ||||||||||||||||
156,200 |
PNC Financial Services Group, Inc. |
9,709,392 | 1.0 | ||||||||||||||||
515,337 |
PPL Corp. |
15,114,834 | 1.6 | ||||||||||||||||
144,000 |
Procter & Gamble Co. |
9,675,360 | 1.0 | ||||||||||||||||
324,720 |
Spectra Energy Corp. |
9,176,587 | 1.0 | ||||||||||||||||
246,300 |
St. Jude Medical, Inc. |
9,300,288 | 1.0 | ||||||||||||||||
114,000 |
Time Warner Cable, Inc. |
10,125,480 | 1.1 | ||||||||||||||||
307,000 |
UGI Corp. |
9,357,360 | 1.0 | ||||||||||||||||
122,500 |
United Technologies Corp. |
9,781,625 | 1.1 | ||||||||||||||||
63,300 |
VF Corp. |
9,664,644 | 1.0 | ||||||||||||||||
1,756,100 |
Other Securities |
17,032,795 | 1.9 | ||||||||||||||||
370,498,056 | 39.9 | ||||||||||||||||||
Total Common Stock (Cost $889,094,314) |
916,515,813 | 98.8 |
# of Contracts |
|
|
|
Value |
|
Percentage of Net Assets |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PURCHASED OPTIONS: 0.0% |
|||||||||||||||||||
Options on Currencies: 0.0% |
|||||||||||||||||||
17,000,000 |
@ |
Call USD/JPY, Strike @ 82.600, Exp. 11/19/12 Counterparty: Citigroup, Inc. |
30,038 | 0.0 | |||||||||||||||
16,250,000 |
@ |
Call USD/JPY, Strike @ 81.250, Exp. 10/22/12 Counterparty: Barclays Bank PLC |
27,463 | 0.0 | |||||||||||||||
16,250,000 |
@ |
Call USD/JPY, Strike @ 83.470, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
577 | 0.0 | |||||||||||||||
18,000,000 |
@ |
Put
EUR/USD, Strike @ 1.165, Exp. 10/22/12 Counterparty: Barclays Bank PLC |
18,359 | 0.0 | |||||||||||||||
16,000,000 |
@ |
Put
EUR/USD, Strike @ 1.198, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
8,594 | 0.0 | |||||||||||||||
10,000,000 |
@ |
Put
EUR/USD, Strike @ 1.179, Exp. 11/19/12 Counterparty: JPMorgan Chase & Co. |
35,607 | 0.0 | |||||||||||||||
20,000,000 |
@ |
Put
GBP/USD, Strike @ 1.516, Exp. 11/19/12 Counterparty: Deutsche Bank AG |
55,722 | 0.0 | |||||||||||||||
17,500,000 |
@ |
Put
GBP/USD, Strike @ 1.506, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
977 | 0.0 | |||||||||||||||
18,500,000 |
@ |
Put GBP/USD, Strike @ 1.517, Exp. 10/22/12 Counterparty: Deutsche Bank AG |
21,466 | 0.0 | |||||||||||||||
198,803 | 0.0 | ||||||||||||||||||
Total Purchased Options (Cost $855,025) |
198,803 | 0.0 | |||||||||||||||||
Total Investments in Securities (Cost $889,949,339) |
$ | 916,714,616 | 98.8 | ||||||||||||||||
Assets in Excess of Other Liabilities |
11,165,167 | 1.2 | |||||||||||||||||
Net Assets |
$ | 927,879,783 | 100.0 |
@ |
Non-income producing security |
|
ADR |
American Depositary Receipt | |
Cost for federal income tax purposes is $890,721,020. |
Net unrealized
appreciation consists of: |
||||||
Gross
Unrealized Appreciation |
$ | 70,607,240 | ||||
Gross
Unrealized Depreciation |
(44,613,644 | ) | ||||
Net
Unrealized Appreciation |
$ | 25,993,596 |
Sector Diversification |
Percentage of Net Assets |
|||||
---|---|---|---|---|---|---|
Financials |
19.2 | % | ||||
Health
Care |
13.2 | |||||
Industrials |
12.6 | |||||
Energy |
10.8 | |||||
Consumer
Staples |
9.0 | |||||
Information
Technology |
8.5 | |||||
Consumer
Discretionary |
7.9 | |||||
Telecommunication Services |
6.4 | |||||
Materials |
6.1 | |||||
Utilities |
5.1 | |||||
Options on
Currencies |
0.0 | |||||
Assets in
Excess of Other Liabilities |
1.2 | |||||
Net
Assets |
100.0 | % |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
SUMMARY PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) (CONTINUED) |
Quoted Prices in Active Markets for Identical Investments (Level 1) |
Significant Other Observable Inputs# (Level 2) |
Significant Unobservable Inputs (Level 3) |
Fair Value at August 31, 2012 |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asset
Table |
||||||||||||||||||
Investments,
at fair value |
||||||||||||||||||
Common
Stock |
||||||||||||||||||
Australia |
$ | | $ | 25,984,336 | $ | | $ | 25,984,336 | ||||||||||
Brazil |
4,943,316 | | | 4,943,316 | ||||||||||||||
Canada |
29,754,894 | | | 29,754,894 | ||||||||||||||
France |
| 74,593,934 | | 74,593,934 | ||||||||||||||
Germany |
| 54,886,881 | | 54,886,881 | ||||||||||||||
Hong
Kong |
9,557,035 | | | 9,557,035 | ||||||||||||||
Israel |
| 9,164,167 | | 9,164,167 | ||||||||||||||
Japan |
| 74,324,270 | | 74,324,270 | ||||||||||||||
Luxembourg |
| 9,389,622 | | 9,389,622 | ||||||||||||||
Netherlands |
| 34,728,279 | | 34,728,279 | ||||||||||||||
Portugal |
| 4,992,042 | | 4,992,042 | ||||||||||||||
Singapore |
| 15,453,572 | | 15,453,572 | ||||||||||||||
Sweden |
| 15,713,733 | | 15,713,733 | ||||||||||||||
Switzerland |
| 36,012,483 | | 36,012,483 | ||||||||||||||
Taiwan |
9,902,773 | | | 9,902,773 | ||||||||||||||
United
Kingdom |
11,565,792 | 125,050,628 | | 136,616,420 | ||||||||||||||
United
States |
370,498,056 | | | 370,498,056 | ||||||||||||||
Total Common
Stock |
436,221,866 | 480,293,947 | | 916,515,813 | ||||||||||||||
Purchased
Options |
| 198,803 | | 198,803 | ||||||||||||||
Total
Investments, at fair value |
$ | 436,221,866 | $ | 480,492,750 | $ | | $ | 916,714,616 | ||||||||||
Other
Financial Instruments+ |
||||||||||||||||||
Futures |
4,746 | | | 4,746 | ||||||||||||||
Total
Assets |
$ | 436,226,612 | $ | 480,492,750 | $ | | $ | 916,719,362 | ||||||||||
Liabilities
Table |
||||||||||||||||||
Other
Financial Instruments+ |
||||||||||||||||||
Written
Options |
$ | | $ | (13,634,718 | ) | $ | | $ | (13,634,718 | ) | ||||||||
Total
Liabilities |
$ | | $ | (13,634,718 | ) | $ | | $ | (13,634,718 | ) |
ˆ |
See Note 2, Significant Accounting Policies in the Notes to Financial Statements for additional information. | |
+ |
Other Financial Instruments are derivatives not reflected in the Portfolio of Investments and may include open forward foreign currency contracts, equity forwards, futures, swaps, and written options. Forward foreign currency contracts, equity forwards and futures are valued at the unrealized gain (loss) on the instrument. Swaps and written options are valued at the fair value of the instrument. | |
# |
The earlier close of the foreign markets gives rise to the possibility that significant events, including broad market moves, may have occurred in the interim and may materially affect the value of those securities. To account for this, the Fund may frequently value many of its foreign equity securities using fair value prices based on third party vendor modeling tools to the extent available. Accordingly, a portion of the Funds investments are categorized as Level 2 investments. | |
There were no transfers in or out of Levels 1, 2 or 3 of the fair value hierarchy during the period ended August 31, 2012. |
Contract Description |
Number of Contracts |
Expiration Date |
Notional Value |
Unrealized Appreciation/ (Depreciation) |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long
Contracts |
||||||||||||||||||
Euro STOXX
50® Index |
1 | 09/21/12 | $ | 30,640 | $ | 87 | ||||||||||||
S&P 500
E-Mini |
1 | 09/21/12 | 70,255 | 15 | ||||||||||||||
$ | 100,895 | $ | 102 |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
SUMMARY PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) (CONTINUED) |
Contract Description |
Number of Contracts |
Expiration Date |
Notional Value |
Unrealized Appreciation/ (Depreciation) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Short
Contracts |
||||||||||||||||||
FTSE 100
Index |
(1 | ) | 09/21/12 | $ | (90,484 | ) | $ | 1,202 | ||||||||||
Nikkei 225
Index |
(1 | ) | 09/13/12 | (112,651 | ) | 3,442 | ||||||||||||
$ | (203,135 | ) | $ | 4,644 |
# of Contracts |
Counterparty |
Description |
Exercise Price |
Expiration Date |
Premiums Received |
Fair Value |
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Options on Indices |
||||||||||||||||||||||||||||
6,800 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,284.560 EUR |
09/07/12 | $ | 531,521 | $ | (1,344,813 | ) | |||||||||||||||||||
6,700 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,372.095 EUR |
09/21/12 | 600,298 | (815,974 | ) | |||||||||||||||||||||
4,700 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,463.000 EUR |
10/05/12 | 415,485 | (327,656 | ) | |||||||||||||||||||||
2,400 |
Barclays Bank PLC |
Call on FTSE 100 Index |
5,646.472 GBP |
09/07/12 | 465,550 | (338,881 | ) | |||||||||||||||||||||
2,500 |
Barclays Bank PLC |
Call on FTSE 100 Index |
5,842.287
GBP |
10/05/12 | 455,679 | (191,116 | ) | |||||||||||||||||||||
2,500 |
UBS Warburg LLC |
Call on FTSE 100 Index |
5,741.800 GBP |
09/21/12 | 467,017 | (255,310 | ) | |||||||||||||||||||||
175,600 |
Barclays Bank PLC |
Call on Nikkei 225 Index |
8,602.170 JPY |
09/21/12 | 429,790 | (666,870 | ) | |||||||||||||||||||||
176,800 |
Royal Bank of Scotland PLC |
Call on Nikkei 225 Index |
8,693.690 JPY |
09/07/12 | 428,542 | (413,662 | ) | |||||||||||||||||||||
174,600 |
UBS Warburg LLC |
Call on Nikkei 225 Index |
9,115.740 JPY |
10/05/12 | 475,509 | (141,271 | ) | |||||||||||||||||||||
89,600 |
Barclays Bank PLC |
Call on S&P 500 Index |
1,386.890
USD |
09/21/12 | 2,646,856 | (2,714,411 | ) | |||||||||||||||||||||
91,200 |
Citigroup, Inc. |
Call on S&P 500 Index |
1,414.413
USD |
10/05/12 | 2,538,652 | (1,827,041 | ) | |||||||||||||||||||||
89,700 |
UBS Warburg LLC |
Call on S&P 500 Index |
1,365.977
USD |
09/07/12 | 2,714,699 | (3,733,424 | ) | |||||||||||||||||||||
Options on
Currencies |
||||||||||||||||||||||||||||
18,000,000 |
Barclays Bank PLC |
Call EUR/USD |
1.261 USD |
10/22/12 | 118,800 | (254,214 | ) | |||||||||||||||||||||
16,000,000 |
Barclays Bank PLC |
Call EUR/USD |
1.303 USD |
09/20/12 | 128,000 | (14,024 | ) | |||||||||||||||||||||
10,000,000 |
JPMorgan Chase & Co. |
Call EUR/USD |
1.273 USD |
11/19/12 | 67,000 | (138,894 | ) | |||||||||||||||||||||
17,500,000 |
Barclays Bank PLC |
Call GBP/USD |
1.609 USD |
09/20/12 | 105,000 | (35,186 | ) | |||||||||||||||||||||
20,000,000 |
Deutsche Bank AG |
Call GBP/USD |
1.609 USD |
11/19/12 | 100,000 | (162,757 | ) | |||||||||||||||||||||
18,500,000 |
Deutsche Bank AG |
Call GBP/USD |
1.611 USD |
10/22/12 | 92,500 | (89,531 | ) | |||||||||||||||||||||
16,250,000 |
Barclays Bank PLC |
Put USD/JPY |
76.040 USD |
10/22/12 | 73,125 | (33,070 | ) | |||||||||||||||||||||
16,250,000 |
Barclays Bank PLC |
Put USD/JPY |
77.120 USD |
09/20/12 | 97,500 | (23,669 | ) | |||||||||||||||||||||
17,000,000 |
Citigroup, Inc. |
Put USD/JPY |
76.850 USD |
11/19/12 | 73,100 | (112,944 | ) | |||||||||||||||||||||
Total Written OTC
Options |
$ | 13,024,623 | $ | (13,634,718 | ) |
Derivatives not accounted for as hedging instruments |
Location on Statement of Assets and Liabilities |
Fair Value |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Asset
Derivatives |
||||||||||
Foreign exchange
contracts |
Investments in securities at value* |
$ | 198,803 | |||||||
Equity
contracts |
Net Assets
Unrealized appreciation** |
4,746 | ||||||||
Total Asset
Derivatives |
$ | 203,549 | ||||||||
Liability
Derivatives |
||||||||||
Equity
Contracts |
Written
options, at fair value |
$ | 12,770,429 | |||||||
Foreign exchange
contracts |
Written
options, at fair value |
864,289 | ||||||||
Total
Liability Derivatives |
$ | 13,634,718 |
* |
Includes purchased options. | |
** |
Includes cumulative appreciation/depreciation of futures contracts as reported in the table following the Summary Portfolio of Investments. |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
SUMMARY PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) (CONTINUED) |
Amount of Realized Gain or (Loss) on Derivatives Recognized in Income |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Derivatives not accounted for as hedging instruments |
Investments* |
Futures |
Written options |
Total |
|||||||||||||||
Equity
contracts |
$ | | $ | | $ | (9,086,887 | ) | $ | (9,086,887 | ) | |||||||||
Foreign exchange
contracts |
(305,306 | ) | | 1,827,607 | 1,522,301 | ||||||||||||||
Total |
$ | (305,306 | ) | $ | | $ | (7,259,280 | ) | $ | (7,564,586 | ) |
Change in Unrealized Appreciation or (Depreciation) on Derivatives Recognized in Income |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Derivatives not accounted for as hedging instruments |
Investments* |
Futures |
Written options |
Total |
|||||||||||||||
Equity
contracts |
$ | | $ | 4,746 | $ | 5,241,027 | $ | 5,245,773 | |||||||||||
Foreign exchange
contracts |
(575,642 | ) | | (369,975 | ) | (945,617 | ) | ||||||||||||
Total |
$ | (575,642 | ) | $ | 4,746 | $ | 4,871,052 | $ | 4,300,156 |
* |
Amounts recognized for purchased options are included in net realized gain (loss) on investments and net change in unrealized appreciation or depreciation on investments. |
Indices |
||||||
% of Total Net
Assets against which calls written |
60.11 | % | ||||
Average Days to
Expiration at time written |
49 days | |||||
Average Call
Moneyness* at time written |
OTM/ATM | |||||
Premiums
received for calls |
$ | 12,169,598 | ||||
Value of
calls |
$ | 12,770,429 |
Currencies |
||||||
% of Total Net
Assets against which calls/puts written |
16.36 | % | ||||
Average Days to
Expiration at time written |
92 days | |||||
Average Call
Moneyness* at time written |
OTM | |||||
Premiums
received for calls |
$ | 855,025 | ||||
Value of
calls |
$ | 864,289 |
Currencies |
||||||
% of Total Net
Assets against which Currency calls/puts purchased |
16.36 | % | ||||
Average Days to
Expiration at time purchased |
92 days | |||||
Average Currency
Put Moneyness* at time purchased |
OTM | |||||
Premiums Paid
for puts |
$ | 855,025 | ||||
Value of
puts |
$ | 198,803 |
* |
Moneyness is the term used to describe the relationship between the price of the underlying asset and the options exercise or strike price. For example, a call (buy) option is considered in-the-money when the value of the underlying asset exceeds the strike price. Conversely, a put (sell) option is considered in-the-money when its strike price exceeds the value of the underlying asset. Options are characterized for the purpose of Moneyness as, in-the-money (ITM), out-of-the-money (OTM) or at-the-money (ATM), where the underlying asset value equals the strike price. |
Proposal |
Shares voted for |
Shares voted against or withheld |
Shares abstained |
Total Shares Voted |
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Class I
Trustees |
Colleen D.
Baldwin |
84,852,689.874 | 3,980,693.216 | | 88,833,383.090 | |||||||||||||||||||||||||
Robert W.
Crispin |
82,204,725.816 | 6,628,657.274 | | 88,833,383.090 | ||||||||||||||||||||||||||
Peter S.
Drotch |
84,686,634.443 | 4,146,748.647 | | 88,833,383.090 |
Declaration Date |
Ex-Dividend Date |
Payable Date |
||||||
---|---|---|---|---|---|---|---|---|
January 17, 2012 | February 1, 2012 | February 15, 2012 | ||||||
February 15, 2012 | March 1, 2012 | March 15, 2012 | ||||||
March 15, 2012 | April 2, 2012 | April 16, 2012 | ||||||
April 16, 2012 | May 1, 2012 | May 15, 2012 | ||||||
May 15, 2012 | June 1, 2012 | June 15, 2012 | ||||||
June 15, 2012 | July 2, 2012 | July 16, 2012 | ||||||
July 16, 2012 | August 1, 2012 | August 15, 2012 | ||||||
August 15, 2012 | September 4, 2012 | September 17, 2012 | ||||||
September 17, 2012 | October 1, 2012 | October 15, 2012 | ||||||
October 15, 2012 | November 1, 2012 | November 15, 2012 | ||||||
November 15, 2012 | December 3, 2012 | December 17, 2012 | ||||||
December 17, 2012 | December 27, 2012 | January 15, 2013 |
SAR-UIGD (0812-102412) |
Item 2. Code of Ethics.
Not required for semi-annual filing.
Item 3. Audit Committee Financial Expert.
Not required for semi-annual filing.
Item 4. Principal Accountant Fees and Services.
Not required for semi-annual filing.
Item 5. Audit Committee Of Listed Registrants.
Not required for semi-annual filing.
Item 6. Schedule of Investments.
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) |
Shares |
|
|
|
Value |
|
Percentage of Net Assets |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COMMON STOCK: 98.8% |
|||||||||||||||||||
Australia: 2.8% |
|||||||||||||||||||
1,311,997 |
Amcor Ltd. |
10,232,567 | 1.1 | ||||||||||||||||
1,377,795 |
Insurance Australia Group |
5,933,273 | 0.6 | ||||||||||||||||
955,194 |
Westfield Group |
9,818,496 | 1.1 | ||||||||||||||||
25,984,336 | 2.8 | ||||||||||||||||||
Brazil: 0.5% |
|||||||||||||||||||
240,200 |
Petroleo Brasileiro SA ADR |
4,943,316 | 0.5 | ||||||||||||||||
Canada: 3.2% |
|||||||||||||||||||
130,300 |
Canadian Imperial Bank of Commerce |
10,076,357 | 1.1 | ||||||||||||||||
500,228 |
Shaw Communications, Inc. Class B |
10,230,379 | 1.1 | ||||||||||||||||
209,764 |
TransCanada Corp. |
9,448,158 | 1.0 | ||||||||||||||||
29,754,894 | 3.2 | ||||||||||||||||||
France: 8.1% |
|||||||||||||||||||
273,278 |
Alstom |
9,709,281 | 1.1 | ||||||||||||||||
253,147 |
BNP Paribas |
10,956,228 | 1.2 | ||||||||||||||||
254,309 |
Capgemini S.A. |
9,331,995 | 1.0 | ||||||||||||||||
289,688 |
Cie de Saint-Gobain |
9,921,254 | 1.1 | ||||||||||||||||
173,993 |
Eutelsat Communications |
5,344,199 | 0.6 | ||||||||||||||||
389,902 |
Gaz de France |
9,583,811 | 1.0 | ||||||||||||||||
124,218 |
Sanofi-Aventis |
10,161,005 | 1.1 | ||||||||||||||||
220,825 |
Vinci S.A. |
9,586,161 | 1.0 | ||||||||||||||||
74,593,934 | 8.1 | ||||||||||||||||||
Germany: 5.9% |
|||||||||||||||||||
122,135 |
Bayer AG |
9,458,070 | 1.0 | ||||||||||||||||
203,656 |
DaimlerChrysler AG |
9,960,984 | 1.1 | ||||||||||||||||
1,328,988 |
Deutsche Telekom AG |
15,852,148 | 1.7 | ||||||||||||||||
317,536 |
Metro AG |
9,550,761 | 1.0 | ||||||||||||||||
68,109 |
Muenchener Rueckversicherungs AG |
10,064,918 | 1.1 | ||||||||||||||||
54,886,881 | 5.9 | ||||||||||||||||||
Hong Kong: 1.0% |
|||||||||||||||||||
178,004 |
China Mobile Ltd. ADR |
9,557,035 | 1.0 | ||||||||||||||||
Israel: 1.0% |
|||||||||||||||||||
843,566 |
Israel Chemicals Ltd. |
9,164,167 | 1.0 | ||||||||||||||||
Japan: 8.0% |
|||||||||||||||||||
192,700 |
Astellas Pharma, Inc. |
9,435,859 | 1.0 | ||||||||||||||||
272,000 |
Canon, Inc. |
9,066,375 | 1.0 | ||||||||||||||||
154,900 |
East Japan Railway Co. |
10,399,099 | 1.1 | ||||||||||||||||
890,900 |
Itochu Corp. |
9,086,783 | 1.0 | ||||||||||||||||
1,983,400 |
Mitsubishi UFJ Financial Group, Inc. |
9,066,514 | 1.0 | ||||||||||||||||
645,900 |
Mitsui & Co., Ltd. |
9,072,189 | 1.0 | ||||||||||||||||
959,700 |
Nissan Motor Co., Ltd. |
9,000,082 | 0.9 | ||||||||||||||||
295,300 |
Sumitomo Mitsui Financial Group, Inc. |
9,197,369 | 1.0 | ||||||||||||||||
74,324,270 | 8.0 | ||||||||||||||||||
Luxembourg: 1.0% |
|||||||||||||||||||
634,932 |
ArcelorMittal |
9,389,622 | 1.0 | ||||||||||||||||
Netherlands: 3.8% |
|||||||||||||||||||
1,911,189 |
Aegon NV |
9,810,392 | 1.1 | ||||||||||||||||
1,154,007 |
Koninklijke KPN NV |
9,896,056 | 1.1 | ||||||||||||||||
429,412 |
Royal Dutch Shell PLC |
15,021,831 | 1.6 | ||||||||||||||||
34,728,279 | 3.8 | ||||||||||||||||||
Portugal: 0.5% |
|||||||||||||||||||
2,046,392 |
Energias de Portugal S.A. |
4,992,042 | 0.5 | ||||||||||||||||
Singapore: 1.7% |
|||||||||||||||||||
1,721,000 |
Singapore Telecommunications Ltd. |
4,683,354 | 0.5 | ||||||||||||||||
702,000 |
United Overseas Bank Ltd. |
10,770,218 | 1.2 | ||||||||||||||||
15,453,572 | 1.7 | ||||||||||||||||||
Sweden: 1.7% |
|||||||||||||||||||
1,683,030 |
Telefonaktiebolaget LM Ericsson |
15,713,733 | 1.7 | ||||||||||||||||
Switzerland: 3.9% |
|||||||||||||||||||
265,485 |
Novartis AG |
15,655,815 | 1.7 | ||||||||||||||||
55,300 |
Roche Holding AG Genusschein |
10,053,186 | 1.1 | ||||||||||||||||
42,928 |
@ |
Zurich Financial Services AG |
10,303,482 | 1.1 | |||||||||||||||
36,012,483 | 3.9 | ||||||||||||||||||
Taiwan: 1.1% |
|||||||||||||||||||
673,658 |
Taiwan Semiconductor Manufacturing Co., Ltd. ADR |
9,902,773 | 1.1 | ||||||||||||||||
United Kingdom: 14.7% |
|||||||||||||||||||
109,081 |
AstraZeneca PLC |
5,102,475 | 0.6 | ||||||||||||||||
329,652 |
BHP Billiton PLC |
9,647,720 | 1.1 | ||||||||||||||||
1,424,019 |
BP PLC |
9,988,852 | 1.1 | ||||||||||||||||
2,673,760 |
BT Group PLC |
9,235,935 | 1.0 | ||||||||||||||||
896,836 |
Capita Group PLC |
10,276,771 | 1.1 | ||||||||||||||||
201,600 |
@ |
Ensco PLC |
11,565,792 | 1.2 | |||||||||||||||
1,744,998 |
HSBC Holdings PLC |
15,201,249 | 1.6 | ||||||||||||||||
389,002 |
Imperial Tobacco Group PLC |
15,176,937 | 1.6 | ||||||||||||||||
757,736 |
Land Securities Group PLC |
9,507,247 | 1.0 | ||||||||||||||||
796,021 |
Prudential PLC |
9,943,802 | 1.1 | ||||||||||||||||
177,112 |
Reckitt Benckiser PLC |
10,016,193 | 1.1 | ||||||||||||||||
1,111,063 |
Reed Elsevier PLC |
10,416,656 | 1.1 | ||||||||||||||||
1,972,993 |
Tesco PLC |
10,536,791 | 1.1 | ||||||||||||||||
136,616,420 | 14.7 | ||||||||||||||||||
United States: 39.9% |
|||||||||||||||||||
232,214 |
Abbott Laboratories |
15,219,306 | 1.6 | ||||||||||||||||
255,700 |
Analog Devices, Inc. |
10,161,518 | 1.1 | ||||||||||||||||
684,800 |
Arch Coal, Inc. |
4,184,128 | 0.5 |
ING GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND |
PORTFOLIO OF INVESTMENTS AS OF AUGUST 31, 2012 (UNAUDITED) (CONTINUED) |
Shares |
|
|
|
Value |
|
Percentage of Net Assets | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
295,700 |
Bristol-Myers Squibb Co. |
9,761,057 | 1.1 | |||||||||||||||
271,900 |
Carnival Corp. |
9,429,492 | 1.0 | |||||||||||||||
108,800 |
Caterpillar, Inc. |
9,283,904 | 1.0 | |||||||||||||||
239,900 |
CenturyTel, Inc. |
10,138,174 | 1.1 | |||||||||||||||
89,100 |
Chevron Corp. |
9,993,456 | 1.1 | |||||||||||||||
317,200 |
Dow Chemical Co. |
9,297,132 | 1.0 | |||||||||||||||
216,200 |
Eli Lilly & Co. |
9,709,542 | 1.0 | |||||||||||||||
177,700 |
ExxonMobil Corp. |
15,513,210 | 1.7 | |||||||||||||||
582,300 |
First Niagara Financial Group, Inc. |
4,594,347 | 0.5 | |||||||||||||||
260,400 |
Freeport-McMoRan Copper & Gold, Inc. |
9,403,044 | 1.0 | |||||||||||||||
748,400 |
General Electric Co. |
15,499,364 | 1.7 | |||||||||||||||
489,000 |
Hewlett-Packard Co. |
8,254,320 | 0.9 | |||||||||||||||
135,400 |
Johnson & Johnson |
9,130,022 | 1.0 | |||||||||||||||
426,600 |
JPMorgan Chase & Co. |
15,843,924 | 1.7 | |||||||||||||||
234,871 |
Kraft Foods, Inc. |
9,754,193 | 1.1 | |||||||||||||||
491,300 |
Metlife, Inc. |
16,768,069 | 1.8 | |||||||||||||||
500,700 |
Microsoft Corp. |
15,431,574 | 1.7 | |||||||||||||||
230,400 |
Molson Coors Brewing Co. |
10,262,016 | 1.1 | |||||||||||||||
240,200 |
Northeast Utilities |
9,048,334 | 1.0 | |||||||||||||||
109,000 |
Occidental Petroleum Corp. |
9,266,090 | 1.0 | |||||||||||||||
131,500 |
PepsiCo, Inc. |
9,524,545 | 1.0 | |||||||||||||||
405,658 |
Pfizer, Inc. |
9,679,000 | 1.0 | |||||||||||||||
1,006,192 |
Pitney Bowes, Inc. |
13,442,725 | 1.4 | |||||||||||||||
156,200 |
PNC Financial Services Group, Inc. |
9,709,392 | 1.0 | |||||||||||||||
515,337 |
PPL Corp. |
15,114,834 | 1.6 | |||||||||||||||
144,000 |
Procter & Gamble Co. |
9,675,360 | 1.0 | |||||||||||||||
324,720 |
Spectra Energy Corp. |
9,176,587 | 1.0 | |||||||||||||||
246,300 |
St. Jude Medical, Inc. |
9,300,288 | 1.0 | |||||||||||||||
114,000 |
Time Warner Cable, Inc. |
10,125,480 | 1.1 | |||||||||||||||
307,000 |
UGI Corp. |
9,357,360 | 1.0 | |||||||||||||||
122,500 |
United Technologies Corp. |
9,781,625 | 1.1 | |||||||||||||||
63,300 |
VF Corp. |
9,664,644 | 1.0 | |||||||||||||||
370,498,056 | 39.9 | |||||||||||||||||
Total Common Stock |
||||||||||||||||||
(Cost $889,094,314) |
916,515,813 | 98.8 |
# of Contracts |
|
|
|
Value |
|
Percentage of Net Assets |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PURCHASED OPTIONS: 0.0% |
|||||||||||||||||||
Options on Currencies: 0.0% |
|||||||||||||||||||
17,000,000 |
@ |
Call USD/JPY, Strike @ 82.600, Exp. 11/19/12 Counterparty: Citigroup, Inc. |
30,038 | 0.0 | |||||||||||||||
16,250,000 |
@ |
Call USD/JPY, Strike @ 81.250, Exp. 10/22/12 Counterparty: Barclays Bank PLC |
27,463 | 0.0 | |||||||||||||||
16,250,000 |
@ |
Call USD/JPY, Strike @ 83.470, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
577 | 0.0 | |||||||||||||||
18,000,000 |
@ |
Put EUR/USD, Strike @ 1.165, Exp. 10/22/12 Counterparty: Barclays Bank PLC |
18,359 | 0.0 | |||||||||||||||
16,000,000 |
@ |
Put EUR/USD, Strike @ 1.198, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
8,594 | 0.0 | |||||||||||||||
10,000,000 |
@ |
Put EUR/USD, Strike @ 1.179, Exp. 11/19/12 Counterparty: JPMorgan Chase & Co. |
35,607 | 0.0 | |||||||||||||||
20,000,000 |
@ |
Put GBP/USD, Strike @ 1.516, Exp. 11/19/12 Counterparty: Deutsche Bank AG |
55,722 | 0.0 | |||||||||||||||
17,500,000 |
@ |
Put GBP/USD, Strike @ 1.506, Exp. 09/20/12 Counterparty: Barclays Bank PLC |
977 | 0.0 | |||||||||||||||
18,500,000 |
@ |
Put GBP/USD, Strike @ 1.517, Exp. 10/22/12 Counterparty: Deutsche Bank AG |
21,466 | 0.0 | |||||||||||||||
198,803 | 0.0 | ||||||||||||||||||
Total Purchased Options (Cost $855,025) |
198,803 | 0.0 | |||||||||||||||||
Total Investments in Securities (Cost $889,949,339) |
$ | 916,714,616 | 98.8 | ||||||||||||||||
Assets in Excess of Other Liabilities |
11,165,167 | 1.2 | |||||||||||||||||
Net Assets |
$ | 927,879,783 | 100.0 |
@ |
Non-income producing security | |
ADR |
American Depositary Receipt | |
Cost for federal income tax purposes is $890,721,020. |
Net unrealized
appreciation consists of: |
||||||
Gross
Unrealized Appreciation |
$ | 70,607,240 | ||||
Gross
Unrealized Depreciation |
(44,613,644 | ) | ||||
Net
Unrealized Appreciation |
$ | 25,993,596 |
Sector Diversification |
|
Percentage of Net Assets |
||||
---|---|---|---|---|---|---|
Financials |
19.2 | % | ||||
Health
Care |
13.2 | |||||
Industrials |
12.6 | |||||
Energy |
10.7 | |||||
Consumer
Staples |
9.0 | |||||
Information
Technology |
8.5 | |||||
Consumer
Discretionary |
7.9 | |||||
Telecommunication Services |
6.4 | |||||
Materials |
6.2 | |||||
Utilities |
5.1 | |||||
Options on
Currencies |
0.0 | |||||
Assets in
Excess of Other Liabilities |
1.2 | |||||
Net
Assets |
100.0 | % |
Quoted Prices in Active Markets for Identical Investments (Level 1) |
Significant Other Observable Inputs # (Level 2) |
Significant Unobservable Inputs (Level 3) |
Fair Value at August 31, 2012 |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asset
Table |
||||||||||||||||||
Investments,
at fair value |
||||||||||||||||||
Common
Stock |
||||||||||||||||||
Australia |
$ | | $ | 25,984,336 | $ | | $ | 25,984,336 | ||||||||||
Brazil |
4,943,316 | | | 4,943,316 | ||||||||||||||
Canada |
29,754,894 | | | 29,754,894 | ||||||||||||||
France |
| 74,593,934 | | 74,593,934 | ||||||||||||||
Germany |
| 54,886,881 | | 54,886,881 | ||||||||||||||
Hong
Kong |
9,557,035 | | | 9,557,035 | ||||||||||||||
Israel |
| 9,164,167 | | 9,164,167 | ||||||||||||||
Japan |
| 74,324,270 | | 74,324,270 | ||||||||||||||
Luxembourg |
| 9,389,622 | | 9,389,622 | ||||||||||||||
Netherlands |
| 34,728,279 | | 34,728,279 | ||||||||||||||
Portugal |
| 4,992,042 | | 4,992,042 | ||||||||||||||
Singapore |
| 15,453,572 | | 15,453,572 | ||||||||||||||
Sweden |
| 15,713,733 | | 15,713,733 | ||||||||||||||
Switzerland |
| 36,012,483 | | 36,012,483 | ||||||||||||||
Taiwan |
9,902,773 | | | 9,902,773 | ||||||||||||||
United
Kingdom |
11,565,792 | 125,050,628 | | 136,616,420 | ||||||||||||||
United
States |
370,498,056 | | | 370,498,056 | ||||||||||||||
Total Common
Stock |
436,221,866 | 480,293,947 | | 916,515,813 | ||||||||||||||
Purchased
Options |
| 198,803 | | 198,803 | ||||||||||||||
Total
Investments, at fair value |
$ | 436,221,866 | $ | 480,492,750 | $ | | $ | 916,714,616 | ||||||||||
Other
Financial Instruments+ |
||||||||||||||||||
Futures |
4,746 | | | 4,746 | ||||||||||||||
Total
Assets |
$ | 436,226,612 | $ | 480,492,750 | $ | | $ | 916,719,362 | ||||||||||
Liabilities
Table |
||||||||||||||||||
Other
Financial Instruments+ |
||||||||||||||||||
Written
Options |
$ | | $ | (13,634,718 | ) | $ | | $ | (13,634,718 | ) | ||||||||
Total
Liabilities |
$ | | $ | (13,634,718 | ) | $ | | $ | (13,634,718 | ) |
ˆ |
See Note 2, Significant Accounting Policies in the Notes to Financial Statements for additional information. | |
+ |
Other Financial Instruments are derivatives not reflected in the Portfolio of Investments and may include open forward foreign currency contracts, equity forwards, futures, swaps, and written options. Forward foreign currency contracts, equity forwards and futures are valued at the unrealized gain (loss) on the instrument. Swaps and written options are valued at the fair value of the instrument. | |
# |
The earlier close of the foreign markets gives rise to the possibility that significant events, including broad market moves, may have occurred in the interim and may materially affect the value of those securities. To account for this, the Fund may frequently value many of its foreign equity securities using fair value prices based on third party vendor modeling tools to the extent available. Accordingly, a portion of the Funds investments are categorized as Level 2 investments. | |
There were no transfers in or out of Levels 1, 2 or 3 of the fair value hierarchy during the period ended August 31, 2012. |
Contract Description |
|
Number of Contracts |
|
Expiration Date |
|
Notional Value |
|
Unrealized Appreciation/ (Depreciation) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long
Contracts |
||||||||||||||||||
Euro STOXX
50® Index |
1 | 09/21/12 | $ | 30,640 | $ | 87 | ||||||||||||
S&P 500
E-Mini |
1 | 09/21/12 | 70,255 | 15 | ||||||||||||||
$ | 100,895 | $ | 102 | |||||||||||||||
Short
Contracts |
||||||||||||||||||
FTSE 100
Index |
(1 | ) | 09/21/12 | (90,484 | ) | 1,202 | ||||||||||||
Nikkei 225
Index |
(1 | ) | 09/13/12 | (112,651 | ) | 3,442 | ||||||||||||
$ | (203,135 | ) | $ | 4,644 |
# of Contracts |
|
Counterparty |
|
Description |
|
Exercise Price |
|
Expiration Date |
|
Premiums Received |
|
Fair Value |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Options on Indices |
||||||||||||||||||||||||||
6,800 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,284.560 EUR |
09/07/12 | $ | 531,521 | $ | (1,344,813 | ) | |||||||||||||||||
6,700 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,372.095 EUR |
09/21/12 | 600,298 | (815,974 | ) | |||||||||||||||||||
4,700 |
UBS Warburg LLC |
Call on Euro Stoxx 50® Index |
2,463.000 EUR |
10/05/12 | 415,485 | (327,656 | ) | |||||||||||||||||||
2,400 |
Barclays Bank PLC |
Call on FTSE 100 Index |
5,646.472 GBP |
09/07/12 | 465,550 | (338,881 | ) | |||||||||||||||||||
2,500 |
Barclays Bank PLC |
Call on FTSE 100 Index |
5,842.287
GBP |
10/05/12 | 455,679 | (191,116 | ) | |||||||||||||||||||
2,500 |
UBS Warburg LLC |
Call on FTSE 100 Index |
5,741.800 GBP |
09/21/12 | 467,017 | (255,310 | ) | |||||||||||||||||||
175,600 |
Barclays Bank PLC |
Call on Nikkei 225 Index |
8,602.170 JPY |
09/21/12 | 429,790 | (666,870 | ) | |||||||||||||||||||
176,800 |
Royal Bank of Scotland PLC |
Call on Nikkei 225 Index |
8,693.690 JPY |
09/07/12 | 428,542 | (413,662 | ) | |||||||||||||||||||
174,600 |
UBS Warburg LLC |
Call on Nikkei 225 Index |
9,115.740 JPY |
10/05/12 | 475,509 | (141,271 | ) | |||||||||||||||||||
89,600 |
Barclays Bank PLC |
Call on S&P 500 Index |
1,386.890
USD |
09/21/12 | 2,646,856 | (2,714,411 | ) | |||||||||||||||||||
91,200 |
Citigroup, Inc. |
Call on S&P 500 Index |
1,414.413
USD |
10/05/12 | 2,538,652 | (1,827,041 | ) | |||||||||||||||||||
89,700 |
UBS Warburg LLC |
Call on S&P 500 Index |
1,365.977
USD |
09/07/12 | 2,714,699 | (3,733,424 | ) | |||||||||||||||||||
Options on
Currencies |
||||||||||||||||||||||||||
18,000,000 |
Barclays Bank PLC |
Call EUR/USD |
1.261 USD |
10/22/12 | 118,800 | (254,214 | ) | |||||||||||||||||||
16,000,000 |
Barclays Bank PLC |
Call EUR/USD |
1.303 USD |
09/20/12 | 128,000 | (14,024 | ) | |||||||||||||||||||
10,000,000 |
JPMorgan Chase & Co. |
Call EUR/USD |
1.273 USD |
11/19/12 | 67,000 | (138,894 | ) | |||||||||||||||||||
17,500,000 |
Barclays Bank PLC |
Call GBP/USD |
1.609 USD |
09/20/12 | 105,000 | (35,186 | ) | |||||||||||||||||||
20,000,000 |
Deutsche Bank AG |
Call GBP/USD |
1.609
USD |
11/19/12 | 100,000 | (162,757 | ) | |||||||||||||||||||
18,500,000 |
Deutsche Bank AG |
Call GBP/USD |
1.611 USD |
10/22/12 | 92,500 | (89,531 | ) | |||||||||||||||||||
16,250,000 |
Barclays Bank PLC |
Put USD/JPY |
76.040 USD |
10/22/12 | 73,125 | (33,070 | ) | |||||||||||||||||||
16,250,000 |
Barclays Bank PLC |
Put USD/JPY |
77.120 USD |
09/20/12 | 97,500 | (23,669 | ) | |||||||||||||||||||
17,000,000 |
Citigroup, Inc. |
Put USD/JPY |
76.850 USD |
11/19/12 | 73,100 | (112,944 | ) | |||||||||||||||||||
Total Written OTC
Options |
$ | 13,024,623 | $ | (13,634,718 | ) |
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-end Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-end Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-end Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
The Board has a Nominating Committee for the purpose of considering and presenting to the Board candidates it proposes for nomination to fill Independent Trustee vacancies on the Board. The Committee currently consists of all Independent Trustees of the Board. (6 individuals). The Nominating Committee operates pursuant to a Charter approved by the Board. The primary purpose of the Nominating Committee is to consider and present to the Board the candidates it proposes for nomination to fill vacancies on the Board. In evaluating candidates, the Nominating Committee may consider a variety of factors, but it has not at this time set any specific minimum qualifications that must be met. Specific qualifications of candidates for Board membership will be based on the needs of the Board at the time of nomination.
The Nominating Committee is willing to consider nominations received from shareholders and shall assess shareholder nominees in the same manner as it reviews its own nominees. A shareholder nominee for director should be submitted in writing to the Funds Secretary. Any such shareholder nomination should include at a minimum the following information as to each individual proposed for nomination as trustee: such individuals written consent to be named in the proxy statement as a nominee (if nominated) and to serve as a trustee (if elected), and all information relating to such individual that is required to be disclosed in the solicitation of proxies for election of trustees, or is otherwise required, in each case under applicable federal securities laws, rules and regulations.
The secretary shall submit all nominations received in a timely manner to the Nominating Committee. To be timely, any such submission must be delivered to the Funds Secretary not earlier than the 90th day prior to such meeting and not later than the close of business on the later of the 60th day prior to such meeting or the 10th day following the day on which public announcement of the date of the meeting is first made, by either disclosure in a press release or in a document publicly filed by the Fund with the Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant): ING Global Equity Dividend and Premium Opportunity Fund
By | /s/ Shaun P. Mathews | |
Shaun P. Mathews | ||
President and Chief Executive Officer |
Date: November 1, 2012
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By | /s/ Shaun P. Mathews | |
Shaun P. Mathews President and Chief Executive Officer |
Date: November 1, 2012
By | /s/ Todd Modic | |
Todd Modic Senior Vice President and Chief Financial Officer |
Date: November 1, 2012